Blood Pressure Medicine Losartan Recall Expanded Due to Potential Carcinogen

If you take losartan, read on.

On April 18, the FDA issued a voluntary national recall of Losartan Potassium tablets, USP and Losartan Potassium/Hydrochlorothiazide tablets, USP. In addition to treating high blood pressure, losartan is prescribed to protect the kidneys from damage that can occur in people with type 2 diabetes. Some also take losartan in an effort to lower stroke risk for those with high blood pressure and an enlarged heart.

According to the company that creates the drug, Torrent Pharmaceuticals Ltd, “[the recall] is due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited.”

The statement continues, saying that the recall is expanded to include an additional 36 lots of Losartan Potassium Tablets, USP and 68 lots of Losartan Potassium/Hydrochlorothiazide Tablets, USP.

“The impurity detected in the API is N-Methylnitrosobutyric acid (NMBA). Torrent is only recalling lots of losartan-containing products that contain N-Methylnitrosobutyric acid (NMBA) above the acceptable daily intake levels released by the FDA,” the press release explains of the potentially dangerous compound.

It’s worth noting that as of the statement’s release, the pharmaceutical company had not encountered any reports of adverse events related to this recall. Read the full recall announcement on FDA.gov here, where you can also read the list of the impacted lots.

Currently, Torrent says that those who use the drug “…should continue taking their medication, as the risk of harm to the patient’s health may be higher if the treatment is stopped immediately without any alternative treatment.” They also recommend these patients be sure to talk to their pharmacist or doctor to learn about other treatment options prior to returning to the medication.

In March, Camber Pharmaceuticals Inc. also voluntarily issued a recall of 87 lots of losartan tablets in the United States that were manufactured by Hetero Labs Ltd. in India due to the detection of the same NMBA impurity.


Did you find this article helpful?


Latest News

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Researchers have managed to create artificial red blood cells that can transport medication. Compared to the popular anticoagulant Warfarin, NOAC’s may be superior for treating atrial fibrillation patients with prior intracranial hemorrhage. Also, surgery may be the preferred choice for reducing leg pain in patients with sciatica.  Synthetic Red Blood…

FDA Recalls Metformin and NP Thyroid

FDA Recalls Metformin and NP Thyroid

The FDA has issued a recall of two drugs–NP Thyroid and Metformin–after testing revealed that they weren’t up to code. Read more below, and if you’re taking either medication, please be sure to contact your doctor for how to continue treatment responsibly.  NP Thyroid Recalled Thirteen lots of NP Thyroid,…

  • Advertisement